Clinical Trials Logo
  1. Home
  2. Post-stroke Cognitive Impairment
  3. NCT03519828

Oxidation-reduction Homeostasis in Cognitive Impairment Patients After Stroke

Post-stroke Cognitive Impairment Clinical Trial

Official title:
Effects of Oxidation-reduction Homeostasis on Cognitive Impairment in Patients With Ischemic Stroke

Clinical Trial Summary

Cognitive impairment after ischemic stroke can affect not only the social adaptation ability, but also affect the comprehensive rehabilitation of patients. The damage of cognitive impairment after ischemic stroke is not lower than the body function defect after stroke. Many studies have shown that oxidative stress is one of the pathophysiological mechanisms of ischemic cerebrovascular disease. Many studies have reported that the oxidative-reduction of cells plays an important role in the life activities of organisms, affecting the health, aging and death of the organism. In the recent years, some scholars have suggested that post-stroke cognitive impairment may be related to oxidative-reduction homeostasis of the body, but the relevant evidence is lacking and needs to be further explored. Therefore, the purpose of this study is to explore the effect of oxidation-reduction homeostasis on cognitive impairment in patients with ischemic stroke, and provide a theoretical basis for the prevention and treatment of cognitive impairment after ischemic stroke.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03519828
Study type Observational
Source General Hospital of Shenyang Military Region
Contact
Status Completed
Phase
Start date March 1, 2018
Completion date January 1, 2019
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04318626 - The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment Phase 2
Not yet recruiting NCT06315231 - Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients Phase 2
Withdrawn NCT03202147 - Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI) Phase 2
Recruiting NCT05731310 - Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke Early Phase 1
Recruiting NCT04596072 - A Clinical Trail of Acupuncture and Herbs for Post-stroke Cogntive Impairment N/A
Completed NCT03647319 - Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Post-stroke Cognitive Impairment N/A
Not yet recruiting NCT06316557 - High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment N/A